CDR2L Antibody, Novus Biologicals™
Manufacturer: Novus Biologicals
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NBP191524-Each-of-1 | In Stock | ₹ 43,387.50 |
NBP191524 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 43,387.50
GST (18%): ₹ 7,809.75
Total Price: ₹ 51,197.25
Antigen
CDR2L
Classification
Polyclonal
Conjugate
Unconjugated
Formulation
PBS, 2% Sucrose with 0.09% Sodium Azide
Gene Alias
cerebellar degeneration-related protein 2-like, HUMPPA, paraneoplastic 62 kDa antigen, paraneoplastic antigen
Host Species
Rabbit
Molecular Weight of Antigen
53 kDa
Quantity
100 μL
Primary or Secondary
Primary
Reconstitution
Centrifuge the vial of lyoph antibody at 12,000 x g for 20 seconds. Add 50μL of distilled water. Vortex followed by centrifuge again to pellet the solution.Final concentration is 1mg/mL in PBS buffer.
Content And Storage
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.
Applications
Western Blot
Concentration
0.5 mg/ml
Dilution
Western Blot 1.0 ug/ml
Gene Accession No.
NP_055418
Gene Symbols
CDR2L
Immunogen
Synthetic peptide directed towards the C terminal of human CDR2L. Peptide sequence VQTSRPISRDSSWRDLRGGEEGQGEVKAGEKSLSQHVEAVDKRLEQSQPE.
Purification Method
Affinity purified
Regulatory Status
RUO
Gene ID (Entrez)
30850
Target Species
Human, Rat, Porcine, Canine, Equine
Isotype
IgG
Related Products
Description
- CDR2L Polyclonal specifically detects CDR2L in Human samples
- It is validated for Western Blot.